Real-world weight loss is influenced by adherence, dose tolerability, lifestyle, and metabolic factors
Originally developed to manage type 2 diabetes, GLP-1s have gained recognition for their efficacy in promoting weight loss by mimicking the actions of the glucagon-like peptide-1 hormone, which regulates appetite and insulin secretion
Semaglutide weight loss injections leverage the hormone GLP-1 to regulate blood sugar, curb appetite, and promote weight loss
Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium
Through our curated partnerships with specialized obesity medicine and weight management providers, including 9amHealth, Calibrate, Mark Cuban Cost Plus Drug Company, PBC, FlyteHealth, and Form Health, employers gain access to manufacturer-approved cash-pay pricing for GLP-1s
In a post hoc analysis of SURPASS-4, tirzepatide treatment was associated with a significant reduction in composite renal outcome events (time to first occurrence of at least 40% decline in estimated glomerular filtration rate from baseline, end-stage renal disease, renal-related death, or incident macroalbuminuria) compared with treatment with insulin glargine (HR = 0.58